These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19519554)

  • 1. Impact of aging on the angiogenic potential of the myocardium: implications for angiogenic therapies with emphasis on sirtuin agonists.
    Wykrzykowska JJ; Bianchi C; Sellke FW
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):119-32. PubMed ID: 19519554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis for myocardial ischemia.
    Rosinberg A; Khan TA; Sellke FW; Laham RJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):271-83. PubMed ID: 15151475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review. Pro- and anti-angiogenesis effects of resveratrol.
    Chen Y; Tseng SH
    In Vivo; 2007; 21(2):365-70. PubMed ID: 17436589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis: bench to bedside, have we learned anything?
    Lee SU; Wykrzykowska JJ; Laham RJ
    Toxicol Pathol; 2006; 34(1):3-10. PubMed ID: 16507538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging myocardial angiogenesis.
    Wykrzykowska JJ; Henry TD; Lesser JR; Schwartz RS
    Nat Rev Cardiol; 2009 Oct; 6(10):648-58. PubMed ID: 19736553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights into human coronary collateral development.
    Fujita M; Tambara K
    Heart; 2004 Mar; 90(3):246-50. PubMed ID: 14966033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome.
    Robich MP; Chu LM; Chaudray M; Nezafat R; Han Y; Clements RT; Laham RJ; Manning WJ; Coady MA; Sellke FW
    Surgery; 2010 Aug; 148(2):453-62. PubMed ID: 20570307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of coronary vasculature in ischemic hearts by plant-derived angiogenic compounds.
    Chen H; Peng P; Cheng L; Lin X; Chung SS; Li M
    Int J Cardiol; 2012 Apr; 156(2):148-55. PubMed ID: 21130507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.
    Sabe AA; Potz BA; Elmadhun NY; Liu Y; Feng J; Abid MR; Abbott JD; Senger DR; Sellke FW
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):245-52. PubMed ID: 26478238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in cardiovascular disease: current status and therapeutic potential.
    Sellke FW; Simons M
    Drugs; 1999 Sep; 58(3):391-6. PubMed ID: 10493268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization.
    Lavine KJ; Ornitz DM
    Trends Cardiovasc Med; 2007 Apr; 17(3):77-83. PubMed ID: 17418368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiogenesis in heart].
    Kamiński KA; Winnicka MM; Zdunek I; Musiał WJ
    Przegl Lek; 2007; 64(1):48-53. PubMed ID: 18183832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin treatment enhances the myocardial angiogenic response in diabetes.
    Boodhwani M; Sodha NR; Mieno S; Ramlawi B; Xu SH; Feng J; Clements RT; Ruel M; Sellke FW
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1453-60; discussion 1460. PubMed ID: 18023664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
    Losordo DW; Dimmeler S
    Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
    [No Abstract]   [Full Text] [Related]  

  • 15. The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes.
    Kamaleddin MA
    Ann N Y Acad Sci; 2016 Dec; 1386(1):3-15. PubMed ID: 27880855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanisms of angiogenesis. Medical and therapeutic applications].
    Couffinhal T; Dufourcq P; Daret D; Duplaà C
    Rev Med Interne; 2001 Nov; 22(11):1064-82. PubMed ID: 11817119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP508 (Chrysalin) reverses endothelial dysfunction and increases perfusion and myocardial function in hearts with chronic ischemia.
    Fossum TW; Olszewska-Pazdrak B; Mertens MM; Makarski LA; Miller MW; Hein TW; Kuo L; Clubb F; Fuller GM; Carney DH
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):214-25. PubMed ID: 18757834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II angiogenesis stimulators.
    Ribatti D; Baiguera S
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1157-66. PubMed ID: 23790062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic myocardial angiogenesis.
    Renault MA; Losordo DW
    Microvasc Res; 2007; 74(2-3):159-71. PubMed ID: 17950369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia.
    Matyal R; Chu L; Mahmood F; Robich MP; Wang A; Hess PE; Shahul S; Pinto DS; Khabbaz K; Sellke FW
    J Mol Cell Cardiol; 2012 Dec; 53(6):891-8. PubMed ID: 22982235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.